Captopril is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE), the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Captopril may be used to treat hypertension. It is grouped under the following drug class(es): ACE Inhibitors. Its therapeutic use is listed as antihypertensives and cardiovascular. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Hypertil, Tenosbon, Acepril and Apopril. Its PubChem CID is 44093.
Captopril
| CAS No | 62571-86-2 |
|---|---|
| Molecular Formula | C9H15NO3S |
| Molecular Weight | 217.29 g/mol |
| Synonyms | (2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Captopril is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE), the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII).
The listed CAS number is 62571-86-2.
The listed molecular formula is C9H15NO3S.
The listed molecular weight is 217.29 g/mol.
(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid.
The source lists Hypertil, Tenosbon, Acepril and Apopril.